1. Home
  2. BIO vs FNB Comparison

BIO vs FNB Comparison

Compare BIO & FNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • FNB
  • Stock Information
  • Founded
  • BIO 1952
  • FNB 1864
  • Country
  • BIO United States
  • FNB United States
  • Employees
  • BIO N/A
  • FNB N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • FNB Major Banks
  • Sector
  • BIO Industrials
  • FNB Finance
  • Exchange
  • BIO Nasdaq
  • FNB Nasdaq
  • Market Cap
  • BIO 6.0B
  • FNB 4.9B
  • IPO Year
  • BIO N/A
  • FNB N/A
  • Fundamental
  • Price
  • BIO $257.04
  • FNB $15.87
  • Analyst Decision
  • BIO Strong Buy
  • FNB Strong Buy
  • Analyst Count
  • BIO 4
  • FNB 9
  • Target Price
  • BIO $324.25
  • FNB $17.83
  • AVG Volume (30 Days)
  • BIO 374.5K
  • FNB 3.5M
  • Earning Date
  • BIO 07-31-2025
  • FNB 07-17-2025
  • Dividend Yield
  • BIO N/A
  • FNB 3.00%
  • EPS Growth
  • BIO N/A
  • FNB 3.30
  • EPS
  • BIO N/A
  • FNB 1.27
  • Revenue
  • BIO $2,541,100,000.00
  • FNB $1,517,200,000.00
  • Revenue This Year
  • BIO N/A
  • FNB $15.18
  • Revenue Next Year
  • BIO $3.49
  • FNB $10.02
  • P/E Ratio
  • BIO N/A
  • FNB $12.60
  • Revenue Growth
  • BIO N/A
  • FNB 1.83
  • 52 Week Low
  • BIO $211.43
  • FNB $10.88
  • 52 Week High
  • BIO $387.99
  • FNB $17.70
  • Technical
  • Relative Strength Index (RSI)
  • BIO 65.41
  • FNB 74.22
  • Support Level
  • BIO $245.87
  • FNB $14.50
  • Resistance Level
  • BIO $264.68
  • FNB $16.12
  • Average True Range (ATR)
  • BIO 7.34
  • FNB 0.30
  • MACD
  • BIO 1.84
  • FNB 0.14
  • Stochastic Oscillator
  • BIO 78.94
  • FNB 89.29

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About FNB F.N.B. Corporation

F N B Corp provides a full range of financial services, principally to consumers, corporations, governments and small- to medium-sized businesses. It has three reportable business segments: Community Banking, Wealth Management and Insurance. The majority of revenue is from the Community banking segment. It offers commercial & consumer banking services. Commercial banking solutions include corporate banking, small business banking, investment real estate financing, business credit, capital markets & lease financing. Consumer banking products & services include deposit products, mortgage lending, & consumer lending & a complete suite of mobile & online banking services.

Share on Social Networks: